Singapore markets close in 3 hours 19 minutes

Alterity Therapeutics Limited (PBN0.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
1.34000.0000 (0.00%)
At close: 08:05AM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 14.66M
Enterprise value 4.98M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)661.25
Price/book (mrq)0.82
Enterprise value/revenue -1.09k
Enterprise value/EBITDA 0.70

Trading information

Stock price history

Beta (5Y monthly) 0.64
52-week change 3-31.98%
S&P500 52-week change 323.20%
52-week high 33.8000
52-week low 30.9650
50-day moving average 31.5206
200-day moving average 31.6260

Share statistics

Avg vol (3-month) 332
Avg vol (10-day) 3N/A
Shares outstanding 58.73M
Implied shares outstanding 6N/A
Float 82.54B
% held by insiders 10.00%
% held by institutions 11.08%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 309 Jan 2023

Financial highlights

Currency in AUD.

Fiscal year

Fiscal year ends 30 Jun 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-348.40%

Management effectiveness

Return on assets (ttm)-28.94%
Return on equity (ttm)-53.72%

Income statement

Revenue (ttm)3.43M
Revenue per share (ttm)0.60
Quarterly revenue growth (yoy)-20.30%
Gross profit (ttm)N/A
EBITDA -12.83M
Net income avi to common (ttm)-12.28M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)12.32M
Total cash per share (mrq)0
Total debt (mrq)255.6k
Total debt/equity (mrq)1.45%
Current ratio (mrq)4.89
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-14.61M
Levered free cash flow (ttm)-9.95M